Literature DB >> 12815170

[125I]A-312110, a novel high-affinity 1,4-dihydropyridine ATP-sensitive K+ channel opener: characterization and pharmacology of binding.

Rachel Davis-Taber1, Eduardo J Molinari, Robert J Altenbach, Kristi L Whiteaker, Char-Chang Shieh, Gary Rotert, Steven A Buckner, John Malysz, Ivan Milicic, Jeffrey S McDermott, Gary A Gintant, Michael J Coghlan, William A Carroll, Victoria E Scott, Murali Gopalakrishnan.   

Abstract

Although ATP-sensitive K+ channels continue to be explored for their therapeutic potential, developments in high-affinity radioligands to investigate native and recombinant KATP channels have been less forthcoming. This study reports the identification and pharmacological characterization of a novel iodinated 1,4-dihydropyridine KATP channel opener, [125I]A-312110 [(9R)-9-(4-fluoro-3-125iodophenyl)-2,3,5,9-tetrahydro-4H-pyrano[3,4-b]thieno[2,3-e]pyridin-8(7H)-one-1,1-dioxide]. Binding of [125I]A-312110 to guinea pig cardiac (KD = 5.8 nM) and urinary bladder (KD = 4.9 nM) membranes were of high affinity, saturable, and to a single set of binding sites. Displacement of [125I]A-312110 by structurally diverse potassium channel openers (KCOs) indicated a similar rank order of potency in both guinea pig cardiac and bladder membranes (Ki, heart): A-312110 (4.3 nM) > N-cyano-N'-(1,1-dimethylpropyl)-N"-3-pyridylguanidine (P1075) > (-)-N-(2-ethoxyphenyl)-N'-(1,2,3-trimethylpropyl)-2-nitroethene-1,1-diamine (Bay X 9228) > pinacidil > (-)-cromakalim > N-(4-benzoyl phenyl)-3,3,3-trifluro-2-hydroxy-2-methylpropionamine (ZD6169) > 9-(3-cyanophenyl)-3,4,6,7,9,10-hexahydro-1,8-(2H,5H)-acridinedione (ZM244085) >> diazoxide (16.7 microM). Displacement by KATP channel blockers, the sulfonylurea glyburide, and the cyanoguanidine N-[1-(3-chlorophenyl)cyclobutyl]-N'-cyano-N"-3-pyridinyl-guanidine (PNU-99963) were biphasic in the heart but monophasic in bladder with about a 100- to 500-fold difference in Ki values between high- and low-affinity sites. Good correlations were observed between cardiac or bladder-binding affinities of KCOs with functional activation as assessed by their respective potencies to either suppress action potential duration (APD) in Purkinje fibers or to relax electrical field-stimulated bladder contractions. Collectively, these results demonstrate that [125I]A-312110 binds with high affinity and has an improved activity profile compared with other radiolabeled KCOs. [125I]A-312110 is a useful tool for investigation of the molecular and functional properties of the KATP channel complex and for the identification, in a high throughput manner, of both novel channel blockers and openers that interact with cardiac/smooth muscle-type KATP channels.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12815170     DOI: 10.1124/mol.64.1.143

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  5 in total

Review 1.  Role of potassium ion channels in detrusor smooth muscle function and dysfunction.

Authors:  Georgi V Petkov
Journal:  Nat Rev Urol       Date:  2011-12-13       Impact factor: 14.432

Review 2.  Innovative pharmacotherapies for women with overactive bladder: where are we now and what is in the pipeline?

Authors:  Emilio Sacco; Riccardo Bientinesi
Journal:  Int Urogynecol J       Date:  2014-11-07       Impact factor: 2.894

3.  Pharmacological characterization of a 1,4-dihydropyridine analogue, 9-(3,4-dichlorophenyl)-3,3,6,6-tetramethyl-3,4,6,7,9,10-hexahydro-1,8(2H,5H)-acridinedione (A-184209) as a novelK(ATP) channel inhibitor.

Authors:  Murali Gopalakrishnan; Thomas R Miller; Steven A Buckner; Ivan Milicic; Eduardo J Molinari; Kristi L Whiteaker; Rachel Davis-Taber; Victoria E Scott; Christopher Cassidy; James P Sullivan; William A Carroll
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

4.  In vitro and in vivo characterization of a novel naphthylamide ATP-sensitive K+ channel opener, A-151892.

Authors:  Murali Gopalakrishnan; Steven A Buckner; Char-Chang Shieh; Thomas Fey; Adebola Fabiyi; Kristi L Whiteaker; Rachel Davis-Taber; Ivan Milicic; Anthony V Daza; Victoria E S Scott; Neil A Castle; David Printzenhoff; Brecht London; Sean C Turner; William A Carroll; James P Sullivan; Michael J Coghlan; Michael E Brune
Journal:  Br J Pharmacol       Date:  2004-08-09       Impact factor: 8.739

5.  Interaction of a novel dihydropyridine K+ channel opener, A-312110, with recombinant sulphonylurea receptors and KATP channels: comparison with the cyanoguanidine P1075.

Authors:  Holger Felsch; Ulf Lange; Annette Hambrock; Cornelia Löffler-Walz; Ulrich Russ; William A Carroll; Murali Gopalakrishnan; Ulrich Quast
Journal:  Br J Pharmacol       Date:  2004-03-15       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.